Smaio S.A (ALSMA) | Stock Overview & Key Data
Smaio S.A. | Small-cap | Healthcare
Smaio S.A. | Small-cap | Healthcare
Smaio S.A Performance Comparison
Stock Range
Today's Range
Low: €6.35
High: €6.80
on July 18, 2025
52 Week Range
Low: €2.25
High: €6.80
on November 27, 2024
on July 18, 2025
All-Time High: €6.80 on July 18, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€36.9M
EPS
-0.18
P/E Ratio (TTM)
16.30
Forward P/E
28.48
P/B Ratio
4.98
PEG Ratio
-0.09
Div. Yield
N/A
ROE
-29.15%
Beta
0.741
Debt to Equity
33.75
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-45.51%
Profit Margin
-42.73%
Returns and Earnings
Return on Assets (TTM)
-15.55%
Return on Equity (TTM)
-29.15%
EBITDA
€-2.8M
Net Income (TTM)
€-2.3M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€1.05
Quarterly Revenue Growth (YoY)
137.10%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Smaio S.A ALSMA | 36.90M Small-cap | 12.93% | 51.62% | 56.70% | 139.93% | 164.11% | 53.40% | 79.95% | 21.97% |
| Equasens EQS | 772.60M Mid-cap | 3.32% | 9.01% | 44.99% | 37.25% | 14.48% | 4.90% | -37.24% | -37.32% |
| Cegedim S.A CGM | 143.17M Small-cap | -2.80% | -1.42% | -7.96% | -12.97% | -21.51% | -20.31% | -50.48% | -68.00% |
| Abl Diagnostics ABLD | 86.82M Small-cap | 0.00% | 0.00% | -0.91% | 82.89% | 121.54% | 94.64% | -91.42% | 20.31% |
| Intrasense S.A ALINS | 15.22M Small-cap | 0.00% | -9.68% | -3.45% | 12.00% | 12.00% | -6.67% | -15.15% | -66.67% |
| Ama Corp Plc ALAMA | 14.39M Small-cap | 8.00% | 8.00% | 35.00% | 58.82% | 58.82% | 12.50% | -74.53% | -95.91% |
Ownership & Short Interest
Insider Ownership
0.00%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
3K
Average 90-Day Volume
3K
Smaio S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Smaio S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALSMA's 52-week high and low?
- In the last 52 weeks, Smaio S.A reached a high of €6.80 (on July 18, 2025) and a low of €2.25 (on November 27, 2024).
- What is the market cap and P/E ratio for ALSMA?
- Curious about Smaio S.A's size and valuation? Its market capitalization stands at 36.90M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.30, and the forward P/E (looking ahead) is 28.48.
- Does ALSMA pay dividends? If so, what's the yield?
- As for dividends, Smaio S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Smaio S.A's main competitors or similar companies to consider before investing?
When looking at Smaio S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS772.60M Healthcare Health Information Services 4.90% -37.24% Cegedim S.A
CGM143.17M Healthcare Health Information Services -20.31% -50.48% Abl Diagnostics
ABLD86.82M Healthcare Health Information Services 94.64% -91.42% Intrasense S.A
ALINS15.22M Healthcare Health Information Services -6.67% -15.15% Ama Corp Plc
ALAMA14.39M Healthcare Health Information Services 12.50% -74.53% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Smaio S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Smaio S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -29.15%, the Debt to Equity ratio from the most recent quarter is 33.75, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALSMA?
- Looking at Smaio S.A's growth, its revenue over the trailing twelve months (TTM) was €5M. Compared to the same quarter last year (YoY), quarterly revenue grew by 137.10%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALSMA stock is held by insiders and institutions?
- Wondering who owns Smaio S.A stock? Company insiders (like executives and directors) hold about 0.00% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.